市場調査レポート
商品コード
1089646

緑内障手術機器市場:開発段階別、セグメント別、地域・国別、規制経路別、主要企業(2022年)

Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update

出版日: | 発行: GlobalData | ページ情報: 英文 107 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
緑内障手術機器市場:開発段階別、セグメント別、地域・国別、規制経路別、主要企業(2022年)
出版日: 2022年05月13日
発行: GlobalData
ページ情報: 英文 107 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の緑内障手術機器市場について調査し、市場の概要とともに、開発段階別、セグメント別、地域別、規制経路別、承認予定日別のパイプライン製品動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 目次

第2章 イントロダクション

  • 緑内障手術機器の概要

第3章 開発中の製品

  • 緑内障手術機器-開発段階別のパイプライン製品
  • 緑内障手術機器-セグメント別のパイプライン製品
  • 緑内障手術機器-地域別のパイプライン製品
  • 緑内障手術機器-規制経路別のパイプライン製品
  • 緑内障手術機器-承認予定日別のパイプライン製品
  • 緑内障手術機器-進行中の臨床試験

第4章 緑内障手術機器-企業が開発中のパイプライン製品

第5章 緑内障手術機器企業と製品概要

  • Alievio Inc
  • Allergan Ltd
  • Assenti, LLC
  • Avisi Technologies LLC
  • Ciliatech Therapeutics AG
  • Corneat Vision Ltd
  • Eye Sonix
  • Galaxy Ophthalmics Inc
  • Geuder AG
  • Glaucot Teknoloji AS
  • Glaukos Corp
  • InnFocus Inc
  • iScience Interventional Inc
  • iSTAR Medical SA
  • iVeena Delivery Systems Inc
  • Johns Hopkins University
  • Kytogenics Pharmaceuticals Inc
  • Medtronic Plc
  • Meir Medical Center
  • Merz Anteis SA
  • MicroOptx Inc
  • Myra Vision Inc
  • Ocumatrx
  • OcuTherix Inc
  • OPKO Health Inc
  • OptoLight Vision Technology
  • Purdue University
  • Queen's University
  • Rheon Medical SA
  • Sheba Medical Center
  • Sight Sciences Inc
  • Tel Aviv University
  • University of Colorado
  • University of Michigan
  • Westhouse Medical Services Plc

第6章 緑内障手術機器-最近の開発

第7章 付録

図表

List of Tables

List of Tables

  • Glaucoma Surgery Devices - Pipeline Products by Stage of Development
  • Glaucoma Surgery Devices - Pipeline Products by Segment
  • Glaucoma Surgery Devices - Pipeline Products by Territory
  • Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
  • Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
  • Glaucoma Surgery Devices - Ongoing Clinical Trials
  • Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
  • Glaucoma Surgery Devices - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Glaucoma Surgery Devices - Pipeline Products by Stage of Development
  • Glaucoma Surgery Devices - Pipeline Products by Segment
  • Glaucoma Surgery Devices - Pipeline Products by Territory
  • Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
  • Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
  • Glaucoma Surgery Devices - Ongoing Clinical Trials
目次
Product Code: GDME1348EPD

GlobalData's Medical Devices sector report, "Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Glaucoma Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Glaucoma Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Glaucoma Surgery Devices Overview

3 Products under Development

  • 3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
  • 3.2 Glaucoma Surgery Devices - Pipeline Products by Segment
  • 3.3 Glaucoma Surgery Devices - Pipeline Products by Territory
  • 3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
  • 3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials

4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies

  • 4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development

5 Glaucoma Surgery Devices Companies and Product Overview

  • 5.1 Alievio Inc Company Overview
  • 5.2 Allergan Ltd Company Overview
  • 5.3 Assenti, LLC Company Overview
  • 5.4 Avisi Technologies LLC Company Overview
  • 5.5 Ciliatech Therapeutics AG Company Overview
  • 5.6 Corneat Vision Ltd Company Overview
  • 5.7 Eye Sonix Company Overview
  • 5.8 Galaxy Ophthalmics Inc (Inactive) Company Overview
  • 5.9 Geuder AG Company Overview
  • 5.10 Glaucot Teknoloji AS Company Overview
  • 5.11 Glaukos Corp Company Overview
  • 5.12 InnFocus Inc Company Overview
  • 5.13 iScience Interventional Inc Company Overview
  • 5.14 iSTAR Medical SA Company Overview
  • 5.15 iVeena Delivery Systems Inc Company Overview
  • 5.16 Johns Hopkins University Company Overview
  • 5.17 Kytogenics Pharmaceuticals Inc Company Overview
  • 5.18 Medtronic Plc Company Overview
  • 5.19 Meir Medical Center Company Overview
  • 5.20 Merz Anteis SA Company Overview
  • 5.21 MicroOptx Inc Company Overview
  • 5.22 Myra Vision Inc Company Overview
  • 5.23 Ocumatrx Company Overview
  • 5.24 OcuTherix Inc Company Overview
  • 5.25 OPKO Health Inc Company Overview
  • 5.26 OptoLight Vision Technology Company Overview
  • 5.27 Purdue University Company Overview
  • 5.28 Queen's University Company Overview
  • 5.29 Rheon Medical SA Company Overview
  • 5.30 Sheba Medical Center Company Overview
  • 5.31 Sight Sciences Inc Company Overview
  • 5.32 Tel Aviv University Company Overview
  • 5.33 University of Colorado Company Overview
  • 5.34 University of Michigan Company Overview
  • 5.35 Westhouse Medical Services Plc (Inactive) Company Overview

6 Glaucoma Surgery Devices- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer